HuGE Literature Finder
|
||
Records 1-71
|
Association between Certain NSCLC Driver Mutations and Predictive Markers for Chemotherapy or PD-(L)1 Inhibition.
Cancer science 2019 Apr . Liang Wenhua, Guo Minzhang, Pan Zhenkui, Cai Xiuyu, Li Caichen, Zhao Yi, Liang Hengrui, Yang Haiying, Wang Zhen, Chen Wenting, Xu Chuhong, Yang Xinyun, Sun Jianyu, He Ping, Gu Xia, Yin Weiqiang, He Jianxi |
|
PD-L1 expression in ROS1-rearranged non-small cell lung cancer: A study using simultaneous genotypic screening of EGFR, ALK, and ROS1.
Thoracic cancer 2019 01 10 (1): 103-110. Lee Jongmin, Park Chan Kwon, Yoon Hyoung-Kyu, Sa Young Jo, Woo In Sook, Kim Hyo Rim, Kim Sue Youn, Kim Tae-Ju |
|
Association of PD-L1 gene rs4143815 C>G polymorphism and human cancer susceptibility: A systematic review and meta-analysis.
Pathology, research and practice 2018 Dec . Zou Ju, Wu Daichao, Li Tao, Wang Xianwen, Liu Yan, Tan Sij |
|
Immune marker profiling and PD-L1 expression across Non-Small Cell Lung Cancer mutations.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018 Sep . Toki Maria I, Mani Nikita, Smithy James W, Liu Yuting, Altan Mehmet, Wasserman Brad, Tuktamyshov Rasikh, Schalper Kurt, Syrigos Konstantinos N, Rimm David |
|
Effect of mutant variants of the KRAS gene on PD-L1 expression and on the immune microenvironment and association with clinical outcome in lung adenocarcinoma patients.
Lung cancer (Amsterdam, Netherlands) 2018 Jul 121 70-75. Falk Alexander T, Yazbeck Nathalie, Guibert Nicolas, Chamorey Emmanuel, Paquet Agnès, Ribeyre Lydia, Bence Coraline, Zahaf Katia, Leroy Sylvie, Marquette Charles-Hugo, Cohen Charlotte, Mograbi Baharia, Mazières Julien, Hofman Véronique, Brest Patrick, Hofman Paul, Ilié Mari |
|
Strong PD-L1 expression predicts poor response and de novo resistance to EGFR TKIs among non-small cell lung cancer patients with EGFR mutation.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2018 Jul . Su Shan, Dong Zhong-Yi, Xie Zhi, Yan Li-Xu, Li Yu-Fa, Su Jian, Liu Si-Yang, Yin Kai, Chen Rui-Lian, Huang Shu-Mei, Chen Zhi-Hong, Yang Jin-Ji, Tu Hai-Yan, Zhou Qing, Zhong Wen-Zhao, Zhang Xu-Chao, Wu Yi-Lo |
|
Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein-Barr virus status, and cancer genome alterations in metastatic gastric cancer.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2018 Jun . Kawazoe Akihito, Shitara Kohei, Kuboki Yasutoshi, Bando Hideaki, Kojima Takashi, Yoshino Takayuki, Ohtsu Atsushi, Ochiai Atsushi, Togashi Yosuke, Nishikawa Hiroyoshi, Doi Toshihiko, Kuwata Takes |
|
Correlations of PD-L1 gene polymorphisms with susceptibility and prognosis in hepatocellular carcinoma in a Chinese Han population.
Gene 2018 Jun . Xie Qigui, Chen Zhanlei, Xia Liang, Zhao Qiufeng, Yu Haitao, Yang Zhuyi |
|
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay.
Blood cancer journal 2018 Jun 8 (6): 60. Intlekofer Andrew M, Joffe Erel, Batlevi Connie L, Hilden Patrick, He Jie, Seshan Venkatraman E, Zelenetz Andrew D, Palomba M Lia, Moskowitz Craig H, Portlock Carol, Straus David J, Noy Ariela, Horwitz Steven M, Gerecitano John F, Moskowitz Alison, Hamlin Paul, Matasar Matthew J, Kumar Anita, van den Brink Marcel R, Knapp Kristina M, Pichardo Janine D, Nahas Michelle K, Trabucco Sally E, Mughal Tariq, Copeland Amanda R, Papaemmanuil Elli, Moarii Mathai, Levine Ross L, Dogan Ahmet, Miller Vincent A, Younes An |
|
Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers.
British journal of cancer 2018 Jun . Guiu Séverine, Mollevi Caroline, Charon-Barra Céline, Boissière Florence, Crapez Evelyne, Chartron Elodie, Lamy Pierre-Jean, Gutowski Marian, Bourgier Céline, Romieu Gilles, Simony-Lafontaine Joelle, Jacot Willi |
|
Somatic FGFR3 Mutations Distinguish a Subgroup of Muscle-Invasive Bladder Cancers with Response to Neoadjuvant Chemotherapy.
EBioMedicine 2018 Jun . Yang Zhao, Zhang Ruiyun, Ge Yunxia, Qin Xuying, Kang Xing, Wang Yue, Zhang Xu, Song Chengli, Quan Xiaofang, Wang Haifeng, Chen Haige, Li Cho |
|
Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma.
Neoplasia (New York, N.Y.) 2018 May 20 (6): 574-593. Wang Xiaoxiao, Cao Xin, Sun Ruifang, Tang Charlene, Tzankov Alexandar, Zhang Jun, Manyam Ganiraju C, Xiao Min, Miao Yi, Jabbar Kausar, Tan Xiaohong, Pang Yuyang, Visco Carlo, Xie Yan, Dybkaer Karen, Chiu April, Orazi Attilio, Zu Youli, Bhagat Govind, Richards Kristy L, Hsi Eric D, Choi William W L, van Krieken J Han, Huh Jooryung, Ponzoni Maurilio, Ferreri Andrés J M, Møller Michael B, Parsons Ben M, Winter Jane N, Piris Miguel A, Li Shaoying, Miranda Roberto N, Medeiros L Jeffrey, Li Yong, Xu-Monette Zijun Y, Young Ken |
|
Clinicopathological characteristics of POLE mutation in patients with non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2018 Apr 118 57-61. Song Zhengbo, Cheng Guoping, Xu Chunwei, Wang Wenxian, Shao Yang, Zhang Yipi |
|
Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1.
Molecular cancer 2018 Apr 17 (1): 81. Liu Liang, Ruiz Jimmy, O'Neill Stacey S, Grant Stefan C, Petty W Jeffrey, Yang Meng, Chen Kexin, Topaloglu Umit, Pasche Boris, Zhang W |
|
PD-L1 expression in lung adenocarcinoma harboring EGFR mutations or ALK rearrangements.
Lung cancer (Amsterdam, Netherlands) 2018 Apr 118 36-40. Yoneshima Yasuto, Ijichi Kayo, Anai Satoshi, Ota Keiichi, Otsubo Kohei, Iwama Eiji, Tanaka Kentaro, Oda Yoshinao, Nakanishi Yoichi, Okamoto Isa |
|
Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Feb JCO2017757740. Teo Min Yuen, Seier Kenneth, Ostrovnaya Irina, Regazzi Ashley M, Kania Brooke E, Moran Meredith M, Cipolla Catharine K, Bluth Mark J, Chaim Joshua, Al-Ahmadie Hikmat, Snyder Alexandra, Carlo Maria I, Solit David B, Berger Michael F, Funt Samuel, Wolchok Jedd D, Iyer Gopa, Bajorin Dean F, Callahan Margaret K, Rosenberg Jonathan |
|
Clinical and Molecular Predictors of PD-L1 Expression in Non-Small-Cell Lung Cancer: Systematic Review and Meta-analysis.
Clinical lung cancer 2018 Feb . Petrelli Fausto, Maltese Mariangela, Tomasello Gianluca, Conti Barbara, Borgonovo Karen, Cabiddu Mary, Ghilardi Mara, Ghidini Michele, Passalacqua Rodolfo, Barni Sandro, Brighenti Matt |
|
Correlation of PD-1/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancer.
Cancer biomarkers : section A of Disease markers 2018 Feb 21 (2): 287-297. Tan Dan, Sheng Li, Yi Qing-H |
|
Differences in histological features and PD-L1 expression between sporadic microsatellite instability and Lynch-syndrome-associated disease in Japanese patients with colorectal cancer.
International journal of clinical oncology 2018 Jan . Yamada Rin, Yamaguchi Tatsuro, Iijima Takeru, Wakaume Rika, Takao Misato, Koizumi Koichi, Hishima Tsunekazu, Horiguchi Shin-Ichi |
|
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma.
Science (New York, N.Y.) 2018 Jan . Miao Diana, Margolis Claire A, Gao Wenhua, Voss Martin H, Li Wei, Martini Dylan J, Norton Craig, Bossé Dominick, Wankowicz Stephanie M, Cullen Dana, Horak Christine, Wind-Rotolo Megan, Tracy Adam, Giannakis Marios, Hodi Frank Stephen, Drake Charles G, Ball Mark W, Allaf Mohamad E, Snyder Alexandra, Hellmann Matthew D, Ho Thai, Motzer Robert J, Signoretti Sabina, Kaelin William G, Choueiri Toni K, Van Allen Eliezer |
|
Safety, activity and biomarkers of SHR-1210, an anti-PD-1 antibody, for patients with advanced esophageal carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Jan . Huang Jing, Xu Binghe, Mo Hongnan, Zhang Weilong, Chen Xuelian, Wu Dawei, Qu Dong, Wang Xingyuan, Lan Bo, Yang Beibei, Wang Pei, Zhang Hongtu, Yang Qing, Jiao Yu-Ch |
|
Comprehensive analysis of cancers of unknown primary for the biomarkers of response to immune checkpoint blockade therapy.
European journal of cancer (Oxford, England : 1990) 2018 05 94 179-186. Gatalica Zoran, Xiu Joanne, Swensen Jeff, Vranic Sem |
|
EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP).
Lung cancer (Amsterdam, Netherlands) 2018 11 125 265-272. Cardona Andrés F, Rojas Leonardo, Zatarain-Barrón Zyanya Lucia, Freitas Helano C, Granados Sara T, Castillo Omar, Oblitas George, Corrales Luis, Castro Christian D, Ruiz-Patiño Alejandro, Martín Claudio, Pérez María Angelina, González Lisde, Chirinos Luis, Vargas Carlos, Carranza Hernán, Otero Jorge, Rodriguez July, Rodriguez Jenny, Archila Pilar, Lema Mauricio, Acosta Madiedo José, Karachaliu Niki, Wills Beatriz, Pino Luis E, de Lima Vladimir, Rosell Rafael, Arrieta Oscar, |
|
Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer.
PloS one 2018 13 (2): e0192385. Catalano Calogerina, da Silva Filho Miguel Inacio, Frank Christoph, Jiraskova Katerina, Vymetalkova Veronika, Levy Miroslav, Liska Vaclav, Vycital Ondrej, Naccarati Alessio, Vodickova Ludmila, Hemminki Kari, Vodicka Pavel, Weber Alexander N R, Försti As |
|
MET Expression in Advanced Non-Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy.
Clinical lung cancer 2018 07 19 (4): e441-e463. Reis Henning, Metzenmacher Martin, Goetz Moritz, Savvidou Nikoleta, Darwiche Kaid, Aigner Clemens, Herold Thomas, Eberhardt Wilfried E, Skiba Charlotte, Hense Jörg, Virchow Isabel, Westerwick Daniela, Bogner Simon, Ting Saskia, Kasper Stefan, Stuschke Martin, Nensa Felix, Herrmann Ken, Hager Thomas, Schmid Kurt W, Schuler Martin, Wiesweg Marc |
|
Prognostic Significance of NSCLC and Response to EGFR-TKIs of EGFR-Mutated NSCLC Based on PD-L1 Expression.
Anticancer research 2018 02 38 (2): 753-762. Kobayashi Kenichi, Seike Masahiro, Zou Fenfei, Noro Rintaro, Chiba Mika, Ishikawa Arimi, Kunugi Shinobu, Kubota Kaoru, Gemma Akihi |
|
Programmed death-ligand 1 expression and CD8+ tumor-infiltrating lymphocytes in advanced non-small cell lung cancer treated with microwave ablation and chemotherapy.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2018 35 (1): 591-598. Wei Zhigang, Zhan Xuemei, Fan Linlin, Ye Xin, Yang Xia, Huang Guanghui, Li Wenhong, Wang Jiao, Han Xiaoying, Meng Min, Ni Yang, Li Qing |
|
Racial Disparities in the Molecular Landscape of Cancer.
Anticancer research 2018 04 38 (4): 2235-2240. Heath Elisabeth I, Lynce Filipa, Xiu Joanne, Ellerbrock Angela, Reddy Sandeep K, Obeid Elias, Liu Stephen V, Bollig-Fischer Aliccia, Separovic Duska, Vanderwalde A |
|
Programmed Death-Ligand 1 Expression and EGFR Mutations in Multifocal Lung Cancer.
The Annals of thoracic surgery 2017 Dec . Haratake Naoki, Toyokawa Gouji, Takada Kazuki, Kozuma Yuka, Matsubara Taichi, Takamori Shinkichi, Akamine Takaki, Katsura Masakazu, Shoji Fumihiro, Okamoto Tatsuro, Oda Yoshinao, Maehara Yoshihi |
|
Mutational Diversity of Lung Cancer and Associated Lymph Nodes. An Exploratory Prospective Study of 4 Resected cIIIA-N2.
Pathology oncology research : POR 2017 Nov . Legras Antoine, Roussel Hélène, Mangiameli Giuseppe, Arame Alex, Grand Bertrand, Pricopi Ciprian, Badia Alain, Gibault Laure, Badoual Cécile, Fabre Elizabeth, Laurent-Puig Pierre, Blons Hélène, Le Pimpec-Barthes Françoi |
|
Association of Androgen Receptor Expression on Tumor Cells and PD-L1 Expression in Muscle-Invasive and Metastatic Urothelial Carcinoma: Insights for Clinical Research.
Clinical genitourinary cancer 2017 Oct . Necchi Andrea, Lo Vullo Salvatore, Giannatempo Patrizia, Raggi Daniele, Perrone Federica, Nicolai Nicola, Catanzaro Mario, Biasoni Davide, Torelli Tullio, Piva Luigi, Stagni Silvia, Salvioni Roberto, Mariani Luigi, Colecchia Mauriz |
|
Programmed death-1 lignd-1 gene rs2890658 polymorphism associated with the risk of esophageal squamous cell carcinoma in smokers.
Cancer biomarkers : section A of Disease markers 2017 Oct . Zhou Rong-Miao, Li Yan, Liu Jiang-Hui, Wang Na, Huang Xi, Cao Shi-Ru, Shan Bao- |
|
Programmed death-ligand 1 expression and T790M status in EGFR-mutant non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2017 Sep 111 182-189. Hata Akito, Katakami Nobuyuki, Nanjo Shigeki, Okuda Chiyuki, Kaji Reiko, Masago Katsuhiro, Fujita Shiro, Yoshida Hiroshi, Zama Kota, Imai Yukihiro, Hirata Yuk |
|
Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
Human pathology 2017 Aug . Yeo Min-Kyung, Choi Song-Yi, Seong In-Ock, Suh Kwang-Sun, Kim Jin Man, Kim Kyung-H |
|
The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade.
Annals of oncology : official journal of the European Society for Medical Oncology 2017 Aug 28 (8): 1934-1941. Foy J-P, Bertolus C, Michallet M-C, Deneuve S, Incitti R, Bendriss-Vermare N, Albaret M-A, Ortiz-Cuaran S, Thomas E, Colombe A, Py C, Gadot N, Michot J-P, Fayette J, Viari A, Van den Eynde B, Goudot P, Devouassoux-Shisheboran M, Puisieux A, Caux C, Zrounba P, Lantuejoul S, Saintigny |
|
Variant SNPs at the microRNA complementary site in the B7?H1 3'?untranslated region increase the risk of non?small cell lung cancer.
Molecular medicine reports 2017 Jun . Du Wenwen, Zhu Jianjie, Chen Yanbin, Zeng Yuanyuan, Shen Dan, Zhang Nan, Ning Weiwei, Liu Zeyi, Huang Jian- |
|
A gene polymorphism in PD-L1 promoter region is not associated with PD-L1 expression and patients' survival in gastric cancer.
Cancer immunology, immunotherapy : CII 2017 May . Wang Weili, Liao Ping, He Yiji |
|
The correlation between programmed death-ligand 1 expression and driver gene mutations in NSCLC.
Oncotarget 2017 Apr 8 (14): 23517-23528. Yang Haitao, Chen Huijuan, Luo Shuimei, Li Lina, Zhou Sijing, Shen Ruifen, Lin Heng, Xie Xian |
|
Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients.
Scientific reports 2017 Mar 7 45124. Nomizo Takashi, Ozasa Hiroaki, Tsuji Takahiro, Funazo Tomoko, Yasuda Yuto, Yoshida Hironori, Yagi Yoshitaka, Sakamori Yuichi, Nagai Hiroki, Hirai Toyohiro, Kim Young H |
|
Genetic Features of Aflatoxin-associated Hepatocellular Carcinomas.
Gastroenterology 2017 Mar . Zhang Weilong, He Huan, Zang Mengya, Wu Qifeng, Zhao Hong, Lu Ling-Ling, Ma Peiqing, Zheng Hongwei, Wang Nengjin, Zhang Ying, He Siyuan, Chen Xiaoyan, Wu Zhiyuan, Wang Xiaoyue, Cai Jianqiang, Liu Zhihua, Sun Zongtang, Zeng Yi-Xin, Qu Chunfeng, Jiao Yuch |
|
Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).
Lung cancer (Amsterdam, Netherlands) 2017 Feb 104 24-30. Tiseo Marcello, Damato Angela, Longo Lucia, Barbieri Fausto, Bertolini Federica, Stefani Alessandro, Migaldi Mario, Gnetti Letizia, Camisa Roberta, Bordi Paola, Buti Sebastiano, Rossi Giul |
|
Functional polymorphisms in PD-L1 gene are associated with the prognosis of patients with early stage non-small cell lung cancer.
Gene 2017 Jan 599 28-35. Lee Shin Yup, Jung Deuk Kju, Choi Jin Eun, Jin Cheng Cheng, Hong Mi Jeong, Do Sook Kyung, Kang Hyo-Gyoung, Lee Won Kee, Seok Yangki, Lee Eung Bae, Jeong Ji Yun, Shin Kyung Min, Yoo Seung Soo, Lee Jaehee, Cha Seung Ick, Kim Chang Ho, Park Jae Yo |
|
Impact of EGFR-Tyrosine Kinase Inhibitors on Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring EGFR Mutations.
Oncology research and treatment 2017 40 (1-2): 7-13. Igawa Satoshi, Ryuge Shiichiro, Ichinoe Masaaki, Nakashima Hiroyasu, Otani Sakiko, Nakahara Yoshiro, Fukui Tomoya, Sasaki Jiichiro, Kubota Masaru, Katagiri Masato, Murakumo Yoshiki, Satoh Yukitoshi, Sato Yuichi, Masuda Noriyu |
|
Programmed Cell Death Ligand 1 Expression in Resected Lung Adenocarcinomas: Association with Immune Microenvironment.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Nov 11 (11): 1869-1878. Huynh Tiffany G, Morales-Oyarvide Vicente, Campo Meghan J, Gainor Justin F, Bozkurtlar Emine, Uruga Hironori, Zhao Ling, Gomez-Caraballo Maria, Hata Aaron N, Mark Eugene J, Lanuti Michael, Engelman Jeffrey A, Mino-Kenudson Ma |
|
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
The New England journal of medicine 2016 Oct . Reck Martin, Rodríguez-Abreu Delvys, Robinson Andrew G, Hui Rina, Cs?szi Tibor, Fülöp Andrea, Gottfried Maya, Peled Nir, Tafreshi Ali, Cuffe Sinead, O'Brien Mary, Rao Suman, Hotta Katsuyuki, Leiby Melanie A, Lubiniecki Gregory M, Shentu Yue, Rangwala Reshma, Brahmer Julie R, |
|
Targeted next generation sequencing identifies markers of response to PD-1 blockade.
Cancer immunology research 2016 Sep . Johnson Douglas B, Frampton Garrett M, Rioth Matthew J, Yusko Erik, Xu Yaomin, Guo Xingyi, Ennis Riley C, Fabrizio David, Chalmers Zachary R, Greenbowe Joel, Ali Siraj M, Balasubramanian Sohail, Sun James X, He Yuting, Frederick Dennie T, Puzanov Igor, Balko Justin M, Cates Justin M, Ross Jeffrey S, Sanders Catherine, Robins Harlan, Shyr Yu, Miller Vincent, Stephens Philip J, Sullivan Ryan J, Sosman Jeffrey A, Lovly Christine |
|
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology 2016 Sep . Kadara H, Choi M, Zhang J, Cuentas E P, Canales J R, Gaffney S G, Zhao Z, Behrens C, Fujimoto J, Chow C, Yoo Y, Kalhor N, Moran C, Rimm D, Swisher S, Gibbons D L, Heymach J, Kaftan E, Townsend J P, Lynch T J, Schlessinger J, Lee J, Lifton R P, Wistuba I I, Herbst R |
|
Prognostic relevance of genetic variants involved in immune checkpoints in patients with colorectal cancer.
Journal of cancer research and clinical oncology 2016 Aug 142 (8): 1775-80. Yoon Shinkyo, Kang Byung Woog, Park Su Yeon, Kim Hye Jin, Park Jun Seok, Choi Gyu Seog, Kim Jong Gwa |
|
Role of Genomic Instability in Immunotherapy with Checkpoint Inhibitors.
Anticancer research 2016 Aug 36 (8): 4033-8. Yaghmour George, Pandey Manjari, Ireland Catherine, Patel Kruti, Nunnery Sara, Powell Daniel, Baum Scott, Wiedower Eric, Schwartzberg Lee S, Martin Michael |
|
[New molecular classification of colorectal cancer, pancreatic cancer and stomach cancer: Towards "à la carte" treatment?]
Bulletin du cancer 2016 Jun . Dreyer Chantal, Afchain Pauline, Trouilloud Isabelle, André Thier |
|
Clinical Significance of PD-L1 Protein Expression in Surgically Resected Primary Lung Adenocarcinoma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Jun . Takada Kazuki, Okamoto Tatsuro, Shoji Fumihiro, Shimokawa Mototsugu, Akamine Takaki, Takamori Shinkichi, Katsura Masakazu, Suzuki Yuzo, Fujishita Takatoshi, Toyokawa Gouji, Morodomi Yosuke, Okano Shinji, Oda Yoshinao, Maehara Yoshihi |
|
Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma.
Scientific reports 2016 Jun 6 27702. Mullane Stephanie A, Werner Lillian, Rosenberg Jonathan, Signoretti Sabina, Callea Marcella, Choueiri Toni K, Freeman Gordon J, Bellmunt Joaqu |
|
Molecular Profiling of Clear Cell Ovarian Cancers: Identifying Potential Treatment Targets for Clinical Trials.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2016 May 26 (4): 648-54. Friedlander Michael L, Russell Kenneth, Millis Sherri, Gatalica Zoran, Bender Ryan, Voss Andre |
|
Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.
Gut 2016 May . Masugi Yohei, Nishihara Reiko, Yang Juhong, Mima Kosuke, da Silva Annacarolina, Shi Yan, Inamura Kentaro, Cao Yin, Song Mingyang, Nowak Jonathan A, Liao Xiaoyun, Nosho Katsuhiko, Chan Andrew T, Giannakis Marios, Bass Adam J, Hodi F Stephen, Freeman Gordon J, Rodig Scott, Fuchs Charles S, Qian Zhi Rong, Ogino Shu |
|
PD-1/PD-L1 expression in non-small-cell lung cancer and its correlation with EGFR/KRAS mutations.
Cancer biology & therapy 2016 Mar 0. Ji Mei, Liu Yan, Li Qing, Li Xiaodong, Ning Zhonghua, Zhao Weiqing, Shi Hongbing, Jiang Jingting, Wu Changpi |
|
Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma.
European journal of cancer (Oxford, England : 1990) 2016 Feb 57 91-103. Yang Ching-Yao, Lin Mong-Wei, Chang Yih-Leong, Wu Chen-Tu, Yang Pan-Ch |
|
Aggressive tumor microenvironment of solid predominant lung adenocarcinoma subtype harboring with epidermal growth factor receptor mutations.
Lung cancer (Amsterdam, Netherlands) 2016 Jan 91 7-14. Saruwatari Koichi, Ikemura Shinnosuke, Sekihara Keigo, Kuwata Takeshi, Fujii Satoshi, Umemura Shigeki, Kirita Keisuke, Matsumoto Shingo, Yoh Kiyotaka, Niho Seiji, Ohmatsu Hironobu, Ochiai Atsushi, Kohrogi Hirotsugu, Tsuboi Masahiro, Goto Koichi, Ishii Genichi |
|
PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel-cisplatin chemotherapy.
Scientific reports 2016 6 25952. Lee Shin Yup, Jung Deuk Kju, Choi Jin Eun, Jin Cheng Cheng, Hong Mi Jeong, Do Sook Kyung, Kang Hyo-Gyoung, Lee Won Kee, Seok Yangki, Lee Eung Bae, Jeong Ji Yun, Shin Kyung Min, Yoo Seung Soo, Lee Jaehee, Cha Seung Ick, Kim Chang Ho, Park Jae Yo |
|
Programmed death-ligand 1 expression associated with molecular characteristics in surgically resected lung adenocarcinoma.
Journal of translational medicine 2016 06 14 (1): 188. Song Zhengbo, Yu Xinmin, Cheng Guoping, Zhang Yipi |
|
Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status.
European urology 2015 Dec . Messai Yosra, Gad Sophie, Noman Muhammad Zaeem, Le Teuff Gwenael, Couve Sophie, Janji Bassam, Kammerer Solenne Florence, Rioux-Leclerc Nathalie, Hasmim Meriem, Ferlicot Sophie, Baud Véronique, Mejean Arnaud, Mole David Robert, Richard Stéphane, Eggermont Alexander M M, Albiges Laurence, Mami-Chouaib Fathia, Escudier Bernard, Chouaib Sal |
|
UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas.
Cancer research 2015 Dec . Wong Stephen Q, Waldeck Kelly, Vergara Ismael A, Schröder Jan, Madore Jason, Wilmott James S, Colebatch Andrew J, De Paoli-Iseppi Ricardo, Li Jason, Lupat Richard, Semple Timothy, Arnau Gisela Mir, Fellowes Andrew, Leonard J Helen, Hruby George, Mann Graham J, Thompson John F, Cullinane Carleen, Johnston Meredith, Shackleton Mark, Sandhu Shahneen, Bowtell David D L, Johnstone Ricky W, Fox Stephen B, McArthur Grant A, Papenfuss Anthony T, Scolyer Richard A, Gill Anthony J, Hicks Rodney J, Tothill Richard |
|
Analysis of a genetic polymorphism in the costimulatory molecule TNFSF4 with HSCT outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2015 Sep . Jindra Peter T, Conway Susan E, Ricklefs Stacy M, Porcella Stephen F, Anzick Sarah L, Haagenson Mike, Wang Tao, Spellman Stephen, Milford Edgar, Kraft Peter, McDermott David H, Abdi Re |
|
PD-L1 gene polymorphism and high level of plasma soluble PD-L1 protein may be associated with non-small cell lung cancer.
The International journal of biological markers 2015 Sep 0. Cheng Sensen, Zheng Jinsong, Zhu Jingyan, Xie Chao, Zhang Xia, Han Xiao, Song Bao, Ma Yuan, Liu J |
|
Programmed Death-Ligand 1 Expression Predicts Tyrosine Kinase Inhibitor Response and Better Prognosis in a Cohort of Patients With Epidermal Growth Factor Receptor Mutation-Positive Lung Adenocarcinoma.
Clinical lung cancer 2015 Sep 16 (5): e25-35. Lin Cheng, Chen Xiong, Li Meifang, Liu Jingnan, Qi Xingfeng, Yang Wenting, Zhang Hairong, Cai Zhongfu, Dai Yun, Ouyang Xueno |
|
Anaplastic thyroid cancer: outcome and the mutation/expression profiles of potential targets.
Pathology oncology research : POR 2015 Jul 21 (3): 695-701. Wu Hao, Sun Yue, Ye Huihui, Yang Shi, Lee Stephanie L, de las Morenas Anton |
|
The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs.
Oncotarget 2015 Jun 6 (16): 14209-19. Tang Yanna, Fang Wenfeng, Zhang Yaxiong, Hong Shaodong, Kang Shiyang, Yan Yue, Chen Nan, Zhan Jianhua, He Xiaobo, Qin Tao, Li Ge, Tang Wenyi, Peng Peijian, Zhang |
|
Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2015 Jun 10 (6): 910-23. Chen Nan, Fang Wenfeng, Zhan Jianhua, Hong Shaodong, Tang Yanna, Kang Shiyang, Zhang Yaxiong, He Xiaobo, Zhou Ting, Qin Tao, Huang Yan, Yi Xianping, Zhang |
|
Impact of NRAS Mutations for Patients with Advanced Melanoma Treated with Immune Therapies.
Cancer immunology research 2015 Mar 3 (3): 288-95. Johnson Douglas B, Lovly Christine M, Flavin Marisa, Panageas Katherine S, Ayers Gregory D, Zhao Zhiguo, Iams Wade T, Colgan Marta, DeNoble Sarah, Terry Charles R, Berry Elizabeth G, Iafrate A John, Sullivan Ryan J, Carvajal Richard D, Sosman Jeffrey |
|
Variations in genes involved in immune response checkpoints and association with outcomes in patients with resected colorectal liver metastases.
The pharmacogenomics journal 2015 Mar . Stremitzer S, Sunakawa Y, Zhang W, Yang D, Ning Y, Stintzing S, Sebio A, Yamauchi S, Matsusaka S, El-Khoueiry R, Stift J, Wrba F, Gruenberger T, Lenz H |
|
A miR-570 binding site polymorphism in the B7-H1 gene is associated with the risk of gastric adenocarcinoma.
Human genetics 2013 Jun 132 (6): 641-8. Wang Weipeng, Li Fang, Mao Yong, Zhou Huan, Sun Jing, Li Rui, Liu Cuiping, Chen Weichang, Hua Dong, Zhang Xuegua |
|
Association between single nucleotide polymorphism of PD-L1 gene and non-small cell lung cancer susceptibility in a Chinese population.
Asia-Pacific journal of clinical oncology 2012 Nov . Chen YB, Mu CY, Chen C, Huang JA |
- Page last reviewed:Jul 30, 2019
- Page last updated:Oct 10, 2019
- Content source: